Delivery Order SPE2DB22D9367-SPE2DB25FSY53
Award Date 6/18/25
Potential Completion Date 6/20/25
Potential Value $8.3K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- On September 15, 2025, the Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order valued at $4,169.59 to DMS Pharmaceutical Group Inc. for 60 tablets of Xtandi 80 mg. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, will fulfill this order with a performance location in Park Ridge, IL, with an ultimate completion date of September 16, 2025. This delivery order was issued without a set-aside...
- On September 24, 2025, the Defense Logistics Agency (DLA) awarded a delivery order valued at $16,678.36 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for 60 tablets of Xtandi 80 mg. This firm fixed-price delivery order, which is expected to be completed by September 25, 2025, was issued without a set-aside designation. The award represents a single delivery order issued under DMS Pharmaceutical Group's larger Indefinite...
- The Defense Logistics Agency awarded a $8,339.18 firm fixed-price delivery order to DMS Pharmaceutical Group Inc. on May 30, 2025, for the supply of Xtandi 80 mg tablets (60-count units). The award, effective through June 2, 2025, carries no set-aside designation. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will fulfill this order from its Park Ridge location. The company has been registered in the System for Award...
- The Defense Logistics Agency awarded a delivery order valued at $8,339.18 to DMS Pharmaceutical Group Inc. on June 23, 2025, for the supply of Xtandi 80 mg tablets (60-count units). The contract is structured as a firm fixed-price delivery order with an ultimate completion date of June 24, 2025, and will be fulfilled from the vendor's location in Park Ridge, Illinois. This award was made without set-aside designation, allowing DMS Pharmaceutical Group to compete on an unrestricted basis...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $4,169.59 to DMS Pharmaceutical Group Inc. for the supply of Xtandi 80 mg tablets (60-count units). This award, issued on June 3, 2025, with an ultimate completion date of June 4, 2025, represents a single delivery order under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with DLA valued at approximately $500 million through November 2026. The delivery will be fulfilled from the contractor's...
- The Defense Logistics Agency awarded a delivery order valued at $8,339.18 to DMS Pharmaceutical Group Inc. on August 20, 2025, for 60 tablets of Xtandi 80 mg. This delivery order, which is set to be completed by August 21, 2025, represents a firm fixed-price contract with no set-aside designation. The product will be delivered to Park Ridge, Illinois, where the awardee is headquartered. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, was selected to fulfill...
- The U.S. Defense Logistics Agency (DLA), operating under the Medical Supply Chain, awarded a delivery order to DMS Pharmaceutical Group Inc. for the supply of Xtandi 40 mg capsules (120-count units) on September 15, 2025. This firm fixed-price delivery order, valued at $43,113.50, represents a single procurement action under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with the DLA. The contract carries no set-aside designation, allowing the woman-owned small business to...
- The U.S. Defense Logistics Agency (DLA), through the Medical Supply Chain division, awarded a delivery order to DMS Pharmaceutical Group Inc. on August 25, 2025, for the supply of Xtandi 40 mg capsules (120 count units) valued at $4,311.35. This firm fixed-price delivery order, issued under no set-aside designation, is scheduled for completion by August 26, 2025, with fulfillment from the vendor's Park Ridge, Illinois location. DMS Pharmaceutical Group Inc., a woman-owned small business...
- The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order valued at $4,169.59 to DMS Pharmaceutical Group Inc. on September 9, 2025, for the supply of Xtandi 40 mg tablets (120-count units). DMS Pharmaceutical Group, a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform this order at its Park Ridge location with an ultimate completion date of September 10, 2025. This delivery order was issued without a set-aside designation,...
- On August 1, 2025, the Defense Logistics Agency (DLA) awarded a delivery order valued at $4,169.59 to DMS Pharmaceutical Group Inc. for the supply of Xtandi 40 mg tablets (120-count units). This firm fixed-price delivery order is associated with DMS Pharmaceutical Group's larger Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, a $499.999 billion contract vehicle valid through November 2026 that enables the agency to issue delivery orders for comprehensive...